Symbol: |
CGNL1
|
Description: |
cingulin-like 1 [Source:HGNC Symbol;Acc:25931]
|
Location: |
Chr15:57668165-57842925[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:142
Gene |
Compound |
Gen_sig |
Exp_pattern |
CGNL1 |
NSC 106723 |
0.035 |
Up |
CGNL1 |
Crotonosid |
0.04 |
Up |
CGNL1 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.005 |
Up |
CGNL1 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.014 |
Up |
CGNL1 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.024 |
Up |
CGNL1 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.042 |
Up |
CGNL1 |
Bromocriptine methanesulfonate |
0.041 |
Up |
CGNL1 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.038 |
Up |
CGNL1 |
NSC 175296 |
0.032 |
Up |
CGNL1 |
6-Aminotoyocamycin |
0.019 |
Up |
CGNL1 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.042 |
Up |
CGNL1 |
NSC 27413 |
0.038 |
Up |
CGNL1 |
GEL-I-195-1 |
0.032 |
Up |
CGNL1 |
NSC 303769 |
0.002 |
Up |
CGNL1 |
AI 3-63984 |
0.025 |
Up |
Expression pattern: Sensitivity / Resistance
Total:10 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
|
miRNA:
~ Export ~
|
Records:3
Gene |
Gen_transcript |
miRNA |
miR_location |
CGNL1 |
ENST00000281282 |
hsa-mir-145-5p |
Chr5:148810224-148810246[+] |
CGNL1 |
ENST00000281282 |
hsa-mir-557 |
Chr1:168344822-168344844[+] |
CGNL1 |
ENST00000281282 |
hsa-mir-95 |
Chr4:8007039-8007060[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|